These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

2164 related items for PubMed ID: 8222763

  • 1. Fibrinolysis in patients with acute ischaemic heart disease. With particular reference to systemic effects of tissue-type plasminogen activator treatment on fibrinolysis, coagulation and complement pathways.
    Munkvad S.
    Dan Med Bull; 1993 Sep; 40(4):383-408. PubMed ID: 8222763
    [Abstract] [Full Text] [Related]

  • 2. The haemostatic balance in groups of thrombosis-prone patients. With particular reference to fibrinolysis in patients with myocardial infarction.
    Gram J.
    Dan Med Bull; 1990 Jun; 37(3):210-34. PubMed ID: 2192835
    [Abstract] [Full Text] [Related]

  • 3. Haemostasis in oral surgery--the possible pathogenetic implications of oral fibrinolysis on bleeding. Experimental and clinical studies of the haemostatic balance in the oral cavity, with particular reference to patients with acquired and congenital defects of the coagulation system.
    Sindet-Pedersen S.
    Dan Med Bull; 1991 Dec; 38(6):427-43. PubMed ID: 1802633
    [Abstract] [Full Text] [Related]

  • 4. Age dependence of blood fibrinolytic components and the effects of low-dose oral contraceptives on coagulation and fibrinolysis in teenagers.
    Siegbahn A, Ruusuvaara L.
    Thromb Haemost; 1988 Dec 22; 60(3):361-4. PubMed ID: 3149043
    [Abstract] [Full Text] [Related]

  • 5. Pathophysiology and clinical aspects of fibrinolysis and inhibition of coagulation. Experimental and clinical studies with special reference to women on oral contraceptives and selected groups of thrombosis prone patients.
    Jespersen J.
    Dan Med Bull; 1988 Feb 22; 35(1):1-33. PubMed ID: 3277796
    [Abstract] [Full Text] [Related]

  • 6. [Changes of blood coagulative and fibrinolytic system and function of pulmonary vascular endothelium after therapy in patients with acute pulmonary thromboembolism].
    Pang BS, Wang C, Lu Y, Yang YH, Xing GH, Mao YL, Huang XX, Zhai ZG.
    Zhonghua Yi Xue Za Zhi; 2007 Nov 20; 87(43):3074-8. PubMed ID: 18261355
    [Abstract] [Full Text] [Related]

  • 7. Molecular mechanisms of fibrinolysis and their application to fibrin-specific thrombolytic therapy.
    Collen D.
    J Cell Biochem; 1987 Feb 20; 33(2):77-86. PubMed ID: 3553213
    [Abstract] [Full Text] [Related]

  • 8. Fibrin-specific thrombolytic agents.
    Collen D.
    Klin Wochenschr; 1988 Feb 20; 66 Suppl 12():15-23. PubMed ID: 3126344
    [Abstract] [Full Text] [Related]

  • 9. Endothelial cell activation in cutaneous vasculitis.
    Jurd KM, Stephens CJ, Black MM, Hunt BJ.
    Clin Exp Dermatol; 1996 Jan 20; 21(1):28-32. PubMed ID: 8689765
    [Abstract] [Full Text] [Related]

  • 10. Vascular and fibrinolytic effects of intra-arterial tumour necrosis factor-alpha in patients with coronary heart disease.
    Robinson SD, Dawson P, Ludlam CA, Boon NA, Newby DE.
    Clin Sci (Lond); 2006 Mar 20; 110(3):353-60. PubMed ID: 16309383
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. [An experimental study of local fibrinolysis using tissue plasminogen activator and urokinase in a canine common carotid artery thrombus model].
    Kawakami K, Takahashi A, Yoshimoto T.
    No To Shinkei; 1990 Feb 20; 42(2):193-201. PubMed ID: 2113401
    [Abstract] [Full Text] [Related]

  • 13. Familial association of high levels of histidine-rich glycoprotein and plasminogen activator inhibitor-1 with venous thromboembolism.
    Angles-Cano E, Gris JC, Loyau S, Schved JF.
    J Lab Clin Med; 1993 May 20; 121(5):646-53. PubMed ID: 8478593
    [Abstract] [Full Text] [Related]

  • 14. Plasminogen activator inhibitor type-1 determines plasmin formation in patients with ischaemic heart disease.
    Pedersen OD, Gram J, Jespersen J.
    Thromb Haemost; 1995 May 20; 73(5):835-40. PubMed ID: 7482412
    [Abstract] [Full Text] [Related]

  • 15. Interaction between plasminogen activator inhibitor type 1 (PAI-1) bound to fibrin and either tissue-type plasminogen activator (t-PA) or urokinase-type plasminogen activator (u-PA). Binding of t-PA/PAI-1 complexes to fibrin mediated by both the finger and the kringle-2 domain of t-PA.
    Wagner OF, de Vries C, Hohmann C, Veerman H, Pannekoek H.
    J Clin Invest; 1989 Aug 20; 84(2):647-55. PubMed ID: 2503541
    [Abstract] [Full Text] [Related]

  • 16. Coagulation, fibrinolysis, and fibrin deposition in acute lung injury.
    Idell S.
    Crit Care Med; 2003 Apr 20; 31(4 Suppl):S213-20. PubMed ID: 12682443
    [Abstract] [Full Text] [Related]

  • 17. Changes in the fibrinolytic components of cultured human umbilical vein endothelial cells induced by endotoxin, tumor necrosis factor-alpha and interleukin-1alpha.
    Orbe J, Chordá C, Montes R, Páramo JA.
    Haematologica; 1999 Apr 20; 84(4):306-11. PubMed ID: 10190943
    [Abstract] [Full Text] [Related]

  • 18. Fibrinolysis in health and disease: severe abnormalities in systemic lupus erythematosus.
    Glas-Greenwalt P, Kant KS, Allen C, Pollak VE.
    J Lab Clin Med; 1984 Dec 20; 104(6):962-76. PubMed ID: 6239000
    [Abstract] [Full Text] [Related]

  • 19. [Serial changes in hemostatic and fibrinolytic states induced by coronary thrombolytic therapy].
    Goto S, Handa S, Abe S, Takahashi E, Kawai Y, Watanabe K, Yoshikawa T, Hori S, Ikeda Y.
    J Cardiol; 1993 Dec 20; 23(4):335-41. PubMed ID: 8064582
    [Abstract] [Full Text] [Related]

  • 20. [Plasmin-mediated activation of the coagulation system. A study of patients with acute ischemic heart disease treated with recombinant tissue-plasminogen activator].
    Gram JB, Munkvad S, Leebeek FW, Kluft C, Jespersen J.
    Ugeskr Laeger; 1994 May 02; 156(18):2746-8, 2751-2. PubMed ID: 8009715
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 109.